Back to Research Home
ULBIUltralife Corporation
Industrials · Industrial Machinery/Components · Micro
$6.07−1.78%
As of 23 Oct 2026Mkt cap $103M
Stage 13
AVOID
Fundamentals
31.6/75
Technical
10.1/15
Independent
41.6/90
GCAE viewFundamental /75 is below the Stage 13 acceptable-business floor
Price
- 1M
- +0.3%
- 3M
- +12.2%
- 6M
- −19.6%
- 1Y
- −8.7%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- 0.5xHist median 2.3x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 49.7x
- FCF yield
- 2.0%
Quality
- ROIC
- —
- Operating margin
- 6.0%
- FCF margin
- 3.7%
- Current ratio
- 2.8x
Growth
- Revenue growth
- +16.2%Latest FY YoY
- Revenue CAGR
- +18.1%
- EPS CAGR
- —
- FCF CAGR
- +47.3%
Capital
- Share-count trend
- +1.3%3Y annualised
- Net debt
- $44M4.0x OCF
Annual trend
- CAGR 2021–2025
- +18.1%
- Latest · 2025
- $0B
- YoY
- +16.2%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
Fundamental /75 is below the Stage 13 acceptable-business floor
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2026-11-06
More details & evidence
Production decision
- Stage 13
- AVOID
- Technical state
- approaching-support
- Rotation
- headwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded